Currently we test and support the following browsers:
Families and researchers join forces to improve survival rates, reduce side effects.
At St. Jude Children’s Research Hospital a veteran investigator who oversees services and support essential to translating laboratory discoveries into better outcomes for patients is being honored for helping to train the next generation of research associates.
The best dose of a chemotherapy drug for one child is not necessarily the best dose for another. St. Jude scientists are simplifying individualized therapy for children with cancer.
St. Jude investigators have found a way to administer high doses of the potentially life-saving anticancer drug irinotecan to children without causing severe diarrhea.
Monitoring and fine tuning the levels of the cancer drug topotecan in children with neuroblastoma holds promise for maximizing the drug's effectiveness while reducing its toxicity.